Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.49 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA7 | P43166 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | DUSP5 | Q16690 | 2/20 | 0.31 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6292960 | 0.97 | PRKCA (0.49) | PRKCAPRKCDSERPINE1LMNACA12 | |
| SCHEMBL6858608 | 0.91 | PRKCA (0.62) | PRKCAPRKCDSERPINE1LMNACA12 | |
| SCHEMBL6293178 | 0.88 | PRKCA (0.62) | PRKCAPRKCDSERPINE1LMNACA12 | |
| SCHEMBL6855985 | 0.88 | PRKCA (0.59) | PRKCAPRKCD | |
| SCHEMBL6291913 | 0.85 | PRKCA (0.59) | PRKCAPRKCD | |
| SCHEMBL6856599 | 0.83 | PRKCA (0.50) | PRKCAPRKCDSERPINE1LMNACA12 | |
| SCHEMBL6292961 | 0.83 | PRKCA (0.50) | PRKCAPRKCDSERPINE1LMNACA12 | |
| SCHEMBL4606650 | 0.82 | CA12 (0.53) | LMNACA12CA1CA2CA7 | |
| SCHEMBL6856281 | 0.81 | PRKCA (0.43) | PRKCAPRKCDLMNACA12CA1 | |
| SCHEMBL6854226 | 0.80 | CA2 (0.37) | PRKCAPRKCDCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6830859-B2 | Electrostatic latent images; containing barium salt of sulfoisophthalic acid | RICOH COMPANY, LTD. (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20030077534-A1 | Charge control agent and toner using same | RICOH COMPANY, LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030077534-A1 | Charge control agent and toner using same | BET1, SMARCA5, SMARCA1 | PRKCA 4466/4885PRKCD 4692/4885SERPINE1 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.